搜尋結果
Intel used to dominate the U.S. chip industry. Now it's struggling to stay relevant
CNBC· 23 小時前Intel's long-awaited turnaround looks farther away than ever after the company reported ...
ImmunityBio Announces FDA Approval of ANKTIVA®, First-in-Class IL-15 Receptor Agonist for ...
Bastillepost· 5 日前ImmunityBio, Inc. ( NASDAQ: IBRX ), an immunotherapy company, today announced that the U.S. ...